Dianthus Therapeutics (DNTH) Receivables - Net: 2022-2025
Historic Receivables - Net for Dianthus Therapeutics (DNTH) over the last 2 years, with Sep 2025 value amounting to $5.0 million.
- Dianthus Therapeutics' Receivables - Net rose 259.71% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 259.71%. This contributed to the annual value of $294,000 for FY2023, which is 93.74% down from last year.
- Latest data reveals that Dianthus Therapeutics reported Receivables - Net of $5.0 million as of Q3 2025, which was up 12,720.51% from $39,000 recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Receivables - Net ranged from a high of $5.0 million in Q3 2025 and a low of $39,000 during Q2 2025.
- In the last 3 years, Dianthus Therapeutics' Receivables - Net had a median value of $637,500 in 2024 and averaged $1.2 million.
- Its Receivables - Net has fluctuated over the past 5 years, first surged by 499.14% in 2024, then slumped by 95.36% in 2025.
- Over the past 4 years, Dianthus Therapeutics' Receivables - Net (Quarterly) stood at $4.7 million in 2022, then crashed by 93.74% to $294,000 in 2023, then soared by 499.14% to $1.4 million in 2024, then skyrocketed by 259.71% to $5.0 million in 2025.
- Its Receivables - Net stands at $5.0 million for Q3 2025, versus $39,000 for Q2 2025 and $1.0 million for Q1 2025.